BMI, the stock of Badger Meter, Inc. — a Milwaukee-based global manufacturer of flow measurement, water quality, and control solutions for municipal water utilities and industrial customers — suffered a sharp decline of approximately 11.89% in Wednesday's trading session. The stock fell from a previous close of $145.87 to roughly $128.53 as of mid-afternoon, erasing a significant portion of recent gains. The sell-off was triggered by the company's second quarter 2026 earnings release, which, while in line with Wall Street estimates, revealed ongoing year-over-year deterioration in sales, earnings, and operating margins, paired with a cautious full-year outlook that left investors uninspired.
Badger Meter reported Q2 2026 diluted earnings per share of $1.02, down 13% from $1.17 in the prior-year quarter but matching the consensus analyst estimate of approximately $1.02. Revenue came in at $222.3 million, a 7% decline from $238.1 million a year ago, and slightly above the $220–221 million consensus forecast. While these headline numbers did not constitute a formal miss, the year-over-year contraction in both top- and bottom-line performance weighed heavily on investor sentiment.
Operating earnings fell 12% to $39.4 million, with operating margins compressing 110 basis points to 17.7% from 18.8% in the year-ago period. Gross margin slipped 30 basis points to 40.8%, held within the company's normalized range of 39–42% but pressured by lower sales volumes and project mix effects. Free cash flow fell sharply to $21.9 million from $40.6 million a year earlier, reflecting temporary working capital increases tied to uneven project pacing.
Perhaps the most significant weight on the stock was management's reaffirmed outlook for full-year organic revenue to be "flattish" compared to 2025 levels, excluding the contribution from the recently acquired UDlive Limited. CEO Kenneth C. Bockhorst emphasized that sequential quarterly improvement was expected through the remainder of 2026, but the cautious tone around annual growth — particularly against a backdrop where some analysts had modeled more robust second-half acceleration — appeared to disappoint the market.
CFO Dan Weltzin also flagged "increasing levels of electronic component cost and availability pressures" stemming from AI and data center build-out demand, signaling that margin headwinds may persist. The combination of tepid growth guidance and ongoing cost pressures gave investors little reason to bid the stock higher in the immediate aftermath of the report.
Utility water sales — Badger Meter's largest segment — declined 8% year-over-year (9% excluding the UDlive acquisition), driven by the uneven ramp of advanced metering infrastructure (AMI) projects. On a positive note, utility water sales improved 8% sequentially from the first quarter, as several previously awarded projects, including the major PRASA initiative in Puerto Rico, began initial product shipments.
Flow instrumentation products provided a relative bright spot, with sales rising 6% year-over-year, supported by broad-based water application demand and emerging orders tied to data center cooling and flow monitoring. However, this segment alone was insufficient to offset the drag from the larger utility water business.
Trading volume in BMI was significantly elevated on Wednesday, running well above the stock's average daily volume, indicating heavy institutional repositioning following the earnings release. The sell-off in Badger Meter shares occurred against a backdrop of broader caution in industrial and water infrastructure names, as investors reassess the pace of municipal capital spending and the potential impact of sustained higher interest rates on project financing timelines.
The magnitude of the decline — pushing below key technical support levels near $138–140 — suggests that momentum-driven selling amplified the fundamental disappointment. The stock had rallied considerably in recent weeks leading into the earnings report, leaving it vulnerable to a sharp reversal when the results and guidance failed to exceed expectations.
For traders seeking systematic, data-driven approaches to navigate volatile markets, Tickeron's Trending AI Robots page offers a curated selection of top-performing AI trading bots. Tickeron provides hundreds of AI-powered trading bots covering thousands of tickers across equities, ETFs, and cryptocurrencies, but only the strongest performers under current market conditions are highlighted in this dedicated section. These bots differ by strategy — from swing trading to trend following — as well as timeframe, performance metrics, and the symbols they trade. The Trending AI Robots section serves as a streamlined discovery tool for traders who want to identify which automated strategies are delivering results right now, without sifting through the entire bot marketplace. Explore the Trending AI Robots page to see which strategies are currently leading the pack.
Looking ahead, the key variable for BMI will be whether the company's pipeline of awarded AMI projects materializes on schedule during the second half of 2026. Management has indicated that the cohort of nine previously discussed awarded projects "feels pretty solid," with initial shipments already underway for several. Any positive updates on project ramp timelines could help restore investor confidence.
Additionally, the integration of UDlive — the UK-based sewer line monitoring specialist acquired in May 2026 — will be closely watched, as it expands Badger Meter's beyond-the-meter capabilities. On the risk side, ongoing class action litigation related to prior-period disclosures, electronic component cost inflation, and the inherent unpredictability of municipal procurement cycles all represent uncertainties that could keep the stock range-bound in the near term. The next quarterly report will be a critical checkpoint for whether the recovery narrative remains intact.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
BMI saw its Momentum Indicator move below the 0 level on August 14, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 99 similar instances where the indicator turned negative. In of the 99 cases, the stock moved further down in the following days. The odds of a decline are at .
The Moving Average Convergence Divergence Histogram (MACD) for BMI turned negative on August 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .
BMI moved below its 50-day moving average on August 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BMI crossed bearishly below the 50-day moving average on July 31, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BMI's RSI Indicator exited the oversold zone, of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 70 cases where BMI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in of 305 cases, the price rose further within the following month. The odds of a continued upward trend are .
BMI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 210 cases where BMI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BMI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.596) is normal, around the industry mean (4.237). P/E Ratio (30.869) is within average values for comparable stocks, (84.285). Projected Growth (PEG Ratio) (3.315) is also within normal values, averaging (2.058). Dividend Yield (0.012) settles around the average of (0.012) among similar stocks. P/S Ratio (4.399) is also within normal values, averaging (33.077).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a maker of flow measurement and control products
Industry ElectronicEquipmentInstruments